VKH
EGRX

Virtu KCG Holdings’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Virtu KCG Holdings’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,175
Closed -$642K – 3873
2016
Q3 		$642K Buy
+9,175
New +$508K 0.02% 1137
2016
Q2 		– Sell
-9,119
Closed -$369K – 3404
2016
Q1 		$369K Buy
9,119
+6,444
+241% +$409K 0.01% 1488
2015
Q4 		$237K Buy
+2,675
New +$211K ﹤0.01% 2478
2015
Q3 		– Sell
-4,426
Closed -$358K – 3908
2015
Q2 		$358K Buy
+4,426
New +$288K 0.01% 1834

Other funds holding EGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Virtu KCG Holdings's EGRX Position: Q4 2016 in Review

Virtu KCG Holdings sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2016, closing a stake of 9,175 shares — an estimated $642K sold.

Virtu KCG Holdings first reported a position in EGRX in Q2 2015 and held it in 4 quarters. The position peaked at $642K in Q3 2016. 149 funds tracked by Wall St. Rank hold EGRX as of Q4 2016.

  • Virtu KCG Holdings reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 9,175 Eagle Pharmaceuticals, Inc. shares in Q4 2016, an estimated $642K.
  • Virtu KCG Holdings first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 4 quarters.
  • Virtu KCG Holdings's Eagle Pharmaceuticals, Inc. position peaked at $642K in Q3 2016.
  • 149 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.